Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion type Assertion NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_head.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion description "[There was also no effect in a subgroup of patients on carbamazepine, which is thought to be a RLIP76 substrate, although two polymorphisms were associated with time to first seizure (p = 0.007).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_provenance.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion evidence source_evidence_literature NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_provenance.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion SIO_000772 18086001 NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_provenance.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion wasDerivedFrom befree-20150227 NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_provenance.
- NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_assertion wasGeneratedBy ECO_0000203 NP856293.RAxrrRK7kTFPtiWo5zXsj0c4xINI2WaYImw0Ac5rNsVkw130_provenance.